down arrow

Evoq Remedies

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE0JVD01011
  • NSEID:
  • BSEID: 543500
INR
2.86
0.05 (1.78%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 4000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 190.37% vs -80.14% in Mar 2024

stock-summary

Standalone Net Profit

YoY Growth in year ended Mar 2025 is -80.00% vs -72.22% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -35.98% vs 56.15% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Evoq Remedies With
Markets Mojo
Figures in Rs cr
Standalone Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
11.76
8,558.51
-8,546.75
-99.86%
Other Operating Income
0.00
0.00
0.00
Total Operating income
11.76
8,558.51
-8,546.75
-99.86%
Raw Material Cost
0.00
859.11
-859.11
-100.00%
Purchase of Finished goods
12.18
1,825.86
-1,813.68
-99.33%
(Increase) / Decrease In Stocks
0.91
-60.74
61.65
101.50%
Employee Cost
0.07
1,890.84
-1,890.77
-100.00%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
-0.01
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
0.84
1,859.00
-1,858.16
-99.95%
Total Expenditure (Excl Depreciation)
13.99
6,374.07
-6,360.08
-99.78%
Operating Profit (PBDIT) excl Other Income
-2.23
2,184.44
-2,186.67
-100.10%
Other Income
2.41
266.64
-264.23
-99.10%
Operating Profit (PBDIT)
0.18
2,451.08
-2,450.90
-99.99%
Interest
0.00
14.57
-14.57
-100.00%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
0.18
2,436.51
-2,436.33
-99.99%
Depreciation
0.05
317.46
-317.41
-99.98%
Profit Before Tax
0.13
2,119.05
-2,118.92
-99.99%
Tax
0.04
399.17
-399.13
-99.99%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
0.09
1,719.88
-1,719.79
-99.99%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
0.09
1,823.41
-1,823.32
-100.00%
Equity Capital
24.90
40.06
-15.16
-37.84%
Face Value
10.00
1.00
0.00
Reserves
19.64
9,583.75
-9,564.11
-99.80%
Earnings per share (EPS)
0.04
45.52
-45.48
-99.91%
Diluted Earnings per share
0.04
45.45
-45.41
-99.91%
Operating Profit Margin (Excl OI)
-18.96%
25.52%
0.00
-44.48%
Gross Profit Margin
1.53%
28.47%
0.00
-26.94%
PAT Margin
0.77%
20.10%
0.00
-19.33%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 11.76 Cr
in Mar 2025

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2025 is 190.37% vs -80.14% in Mar 2024

Annual - Standalone Net Profit
Standalone Net Profit 0.09 Cr
in Mar 2025

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2025 is -80.00% vs -72.22% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) -2.23 Cr
in Mar 2025

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2025 is -35.98% vs 56.15% in Mar 2024

Annual - Interest
Markets Mojo
No Interest in the last few periods
stock-summary

YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -18.96%
in Mar 2025

Figures in Rs %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024